CLT-003

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCLT-003
Drug Alias NameChirovisDD-001CLT-003
ClassificationSmall molecules
Mechanisms of ActionHypoxia-inducible factor 1 alpha inhibitorsAngiogenesis inhibitors
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degenerationMacular Degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharlesson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharlesson
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaWet age-related macular degenerationMacular Degeneration +[4] 

Other Information

ATC CodeN/A
Related LinksN/A